Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells.

Shirasaki T, Honda M, Shimakami T, Horii R, Yamashita T, Sakai Y, Sakai A, Okada H, Watanabe R, Murakami S, Yi M, Lemon SM, Kaneko S.

J Virol. 2013 May;87(9):5270-86. doi: 10.1128/JVI.03022-12. Epub 2013 Feb 28.

2.

MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α.

Zhang X, Daucher M, Armistead D, Russell R, Kottilil S.

PLoS One. 2013;8(2):e55733. doi: 10.1371/journal.pone.0055733. Epub 2013 Feb 13.

3.

Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.

Bandiera S, Pernot S, El Saghire H, Durand SC, Thumann C, Crouchet E, Ye T, Fofana I, Oudot MA, Barths J, Schuster C, Pessaux P, Heim MH, Baumert TF, Zeisel MB.

J Virol. 2016 Jun 24;90(14):6387-400. doi: 10.1128/JVI.00619-16. Print 2016 Jul 15.

4.

Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cells.

Hou W, Bukong TN, Kodys K, Szabo G.

Alcohol Clin Exp Res. 2013 Apr;37(4):599-608. doi: 10.1111/acer.12005. Epub 2012 Nov 5.

5.

Supporting Role for GTPase Rab27a in Hepatitis C Virus RNA Replication through a Novel miR-122-Mediated Effect.

Chen TC, Hsieh CH, Sarnow P.

PLoS Pathog. 2015 Aug 25;11(8):e1005116. doi: 10.1371/journal.ppat.1005116. eCollection 2015 Aug.

6.

Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells.

Liu X, Wang T, Wakita T, Yang W.

Virology. 2010 Mar 1;398(1):57-67. doi: 10.1016/j.virol.2009.11.036. Epub 2009 Dec 14.

7.

microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.

Spaniel C, Honda M, Selitsky SR, Yamane D, Shimakami T, Kaneko S, Lanford RE, Lemon SM.

PLoS One. 2013 Oct 9;8(10):e76867. doi: 10.1371/journal.pone.0076867. eCollection 2013.

8.

Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.

Lamontagne J, Steel LF, Bouchard MJ.

World J Gastroenterol. 2015 Jun 28;21(24):7375-99. doi: 10.3748/wjg.v21.i24.7375. Review.

9.

Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Mukherjee A, Di Bisceglie AM, Ray RB.

J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.

10.

High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.

Cheng M, Si Y, Niu Y, Liu X, Li X, Zhao J, Jin Q, Yang W.

J Virol. 2013 Sep;87(17):9707-18. doi: 10.1128/JVI.00802-13. Epub 2013 Jul 3.

11.

Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.

Ishida H, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T.

Biochem Biophys Res Commun. 2011 Aug 19;412(1):92-7. doi: 10.1016/j.bbrc.2011.07.049. Epub 2011 Jul 23.

PMID:
21802413
12.

MicroRNA-122-dependent and -independent replication of Hepatitis C Virus in Hep3B human hepatoma cells.

Thibault PA, Huys A, Dhillon P, Wilson JA.

Virology. 2013 Feb 5;436(1):179-90. doi: 10.1016/j.virol.2012.11.007. Epub 2012 Dec 13.

13.

MicroRNA-130a inhibits HCV replication by restoring the innate immune response.

Li S, Duan X, Li Y, Liu B, McGilvray I, Chen L.

J Viral Hepat. 2014 Feb;21(2):121-8. doi: 10.1111/jvh.12131. Epub 2013 Jul 30.

PMID:
24383925
14.

MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.

Hou W, Tian Q, Zheng J, Bonkovsky HL.

Hepatology. 2010 May;51(5):1494-504. doi: 10.1002/hep.23401.

15.

miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.

Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun WS, Li RF, Liu YG.

Oncol Rep. 2011 Nov;26(5):1281-6. doi: 10.3892/or.2011.1375. Epub 2011 Jul 1.

PMID:
21725618
16.

HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.

Israelow B, Narbus CM, Sourisseau M, Evans MJ.

Hepatology. 2014 Oct;60(4):1170-9. doi: 10.1002/hep.27227. Epub 2014 Aug 21.

17.

Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.

Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR.

J Hepatol. 2009 Sep;51(3):446-57. doi: 10.1016/j.jhep.2009.04.025. Epub 2009 Jun 3.

PMID:
19596477
18.

FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.

Dixit U, Pandey AK, Liu Z, Kumar S, Neiditch MB, Klein KM, Pandey VN.

J Virol. 2015 Aug;89(15):7905-21. doi: 10.1128/JVI.00729-15. Epub 2015 May 20.

19.

BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells.

Pan XB, Qu XW, Jiang D, Zhao XL, Han JC, Wei L.

Antiviral Res. 2013 Apr;98(1):54-60. doi: 10.1016/j.antiviral.2013.01.009. Epub 2013 Feb 16.

PMID:
23422647
20.

Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.

Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.

Supplemental Content

Support Center